Compile Data Set for Download or QSAR
Found 62 with Last Name = 'chiesi' and Initial = 'm'
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089055(CHEMBL273811 | N*2*-(4-Ethanesulfonylmethyl-phenyl...)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089048(CHEMBL18163 | N,N-Dimethyl-C-[4-(4-phenylamino-qui...)copy SMILEScopy InChI
Affinity DataIC50: 0.900nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:Compound was tested for rat Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089069(CHEMBL17632 | N-[4-(4-Phenylamino-quinazolin-2-yla...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089060(CHEMBL273597 | Naphthalene-1-sulfonic acid [4-(4-a...)copy SMILEScopy InChI
Affinity DataIC50: 2.70nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 2.90nMAssay Description:Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 2.90nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089036(CHEMBL278881 | Naphthalene-1-sulfonic acid {4-[2-(...)copy SMILEScopy InChI
Affinity DataIC50: 2.90nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089070(4-Methyl-N-[4-(4-phenylamino-quinazolin-2-ylamino)...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089065(CHEMBL279408 | N*2*-(4-Diethylamino-phenyl)-N*4*-p...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089063(Acetic acid 4-(4-phenylamino-quinazolin-2-ylamino)...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089066(CHEMBL276768 | Naphthalene-1-sulfonic acid (4-{[(4...)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089050(CHEMBL16936 | N*2*-(4-Cyclohexyl-phenyl)-N*4*-phen...)copy SMILEScopy InChI
Affinity DataIC50: 20nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089058(CHEMBL276551 | Naphthalene-1-sulfonic acid [6-(4-a...)copy SMILEScopy InChI
Affinity DataIC50: 28nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089054(CHEMBL17352 | N*2*-(4-Methoxy-phenyl)-N*4*-phenyl-...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089044(CHEMBL17686 | [4-(4-Phenylamino-quinazolin-2-ylami...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089033(CHEMBL418359 | Naphthalene-1-sulfonic acid {3-[(4-...)copy SMILEScopy InChI
Affinity DataIC50: 38nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089045(CHEMBL17196 | Naphthalene-1-sulfonic acid [7-(4-am...)copy SMILEScopy InChI
Affinity DataIC50: 44nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089037(CHEMBL17701 | Naphthalene-1-sulfonic acid [8-(4-am...)copy SMILEScopy InChI
Affinity DataIC50: 46nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089046(CHEMBL17022 | Naphthalene-2-sulfonic acid (4-{[(na...)copy SMILEScopy InChI
Affinity DataIC50: 47nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089047(CHEMBL17914 | N*2*-Cyclohexyl-N*4*-phenyl-quinazol...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089043(CHEMBL17417 | N*2*-{2-[1-(Naphthalene-1-sulfonyl)-...)copy SMILEScopy InChI
Affinity DataIC50: 51nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089032(CHEMBL17395 | N-{4-[4-(4-Chloro-phenylamino)-quina...)copy SMILEScopy InChI
Affinity DataIC50: 58nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089040(CHEMBL17483 | N*2*,N*4*-Diphenyl-quinazoline-2,4-d...)copy SMILEScopy InChI
Affinity DataIC50: 80nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089067(CHEMBL17326 | N*2*-(4-Chloro-phenyl)-N*4*-phenyl-q...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089051(CHEMBL17911 | Naphthalene-1-sulfonic acid {4-[(4-a...)copy SMILEScopy InChI
Affinity DataIC50: 110nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089062(1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089057(CHEMBL429053 | N*4*-Phenyl-N*2*-p-tolyl-quinazolin...)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089061(CHEMBL17450 | N*2*-(3-Dibutylamino-propyl)-N*4*-(3...)copy SMILEScopy InChI
Affinity DataIC50: 210nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089031(CHEMBL17427 | N-{4-[4-(4-Chloro-phenylamino)-quina...)copy SMILEScopy InChI
Affinity DataIC50: 250nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089034(CHEMBL17247 | N*2*-(3,4-Dichloro-phenyl)-N*4*-phen...)copy SMILEScopy InChI
Affinity DataIC50: 270nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089053(CHEMBL278677 | Naphthalene-1-sulfonic acid 4-[(4-a...)copy SMILEScopy InChI
Affinity DataIC50: 290nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089056(CHEMBL279181 | N-{4-[4-(4-Chloro-phenylamino)-quin...)copy SMILEScopy InChI
Affinity DataIC50: 310nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089059(CHEMBL16965 | Naphthalene-1-sulfonic acid 3-[(4-am...)copy SMILEScopy InChI
Affinity DataIC50: 380nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089042(CHEMBL17398 | N-{4-[4-(4-Chloro-phenylamino)-quina...)copy SMILEScopy InChI
Affinity DataIC50: 390nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089052(Benzoic acid 4-(4-phenylamino-quinazolin-2-ylamino...)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089049(CHEMBL17454 | N*4*-(4-Chloro-phenyl)-N*2*-(4-methy...)copy SMILEScopy InChI
Affinity DataIC50: 510nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089064(CHEMBL275845 | Naphthalene-1-sulfonic acid (4-{[(4...)copy SMILEScopy InChI
Affinity DataIC50: 710nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089061(CHEMBL17450 | N*2*-(3-Dibutylamino-propyl)-N*4*-(3...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089041(CHEMBL275610 | [1-(Naphthalene-1-sulfonyl)-piperid...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089035(2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 1.89E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 2More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089039(CHEMBL17441 | N*2*-(4-Amino-butyl)-6-phenyl-quinaz...)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089068(CHEMBL277551 | Naphthalene-1-sulfonic acid [(1R,2S...)copy SMILEScopy InChI
Affinity DataIC50: 4.90E+3nMAssay Description:Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 4(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 5.74E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 4More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089039(CHEMBL17441 | N*2*-(4-Amino-butyl)-6-phenyl-quinaz...)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CGP-71683A | CHEMBL17645 | N-{[(1r,4r)...)copy SMILEScopy InChI
Affinity DataIC50: 8.37E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089062(1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...)copy SMILEScopy InChI
Affinity DataIC50: 8.90E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089046(CHEMBL17022 | Naphthalene-2-sulfonic acid (4-{[(na...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089035(2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...)copy SMILEScopy InChI
Affinity DataIC50: 6.00E+4nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KH0MJPPubMed
Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: